You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Drug Price Trends for benzoyl peroxide


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for benzoyl peroxide

Average Pharmacy Cost for benzoyl peroxide

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
BENZOYL PEROXIDE 10% GEL 45802-0308-96 0.22986 GM 2025-11-19
BENZOYL PEROXIDE 10% WASH 35573-0454-08 0.04526 GM 2025-11-19
BENZOYL PEROXIDE 10% WASH 00536-1261-63 0.04600 ML 2025-11-19
BENZOYL PEROXIDE 10% GEL 45802-0308-01 0.18571 GM 2025-11-19
BENZOYL PEROXIDE 10% WASH 00536-1351-42 0.04526 GM 2025-11-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for benzoyl peroxide

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
BENZOYL PEROXIDE 5%/CLINDAMYCIN PO4 1% GEL JR Golden State Medical Supply, Inc. 51672-1381-02 35GM 15.56 0.44457 GM 2023-06-23 - 2028-06-14 FSS
BENZOYL PEROXIDE 5%/CLINDAMYCIN PO4 1% GEL JR Golden State Medical Supply, Inc. 51672-1381-04 50GM 23.52 0.47040 GM 2023-06-15 - 2028-06-14 FSS
BENZOYL PEROXIDE 5%/CLINDAMYCIN PO4 1% GEL JR Golden State Medical Supply, Inc. 51672-1381-04 50GM 24.08 0.48160 GM 2023-06-23 - 2028-06-14 FSS
BENZOYL PEROXIDE 5%/CLINDAMYCIN PO4 1% GEL PU Golden State Medical Supply, Inc. 51672-1381-05 35GM 33.67 0.96200 GM 2023-06-15 - 2028-06-14 FSS
BENZOYL PEROXIDE 5%/CLINDAMYCIN PO4 1.2% GEL, Golden State Medical Supply, Inc. 51672-1366-06 45GM 17.91 0.39800 GM 2023-12-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Benzoyl Peroxide

Last updated: July 27, 2025

Introduction

Benzoyl peroxide (BPO) remains a cornerstone in dermatology, primarily used for treating acne vulgaris. Its enduring efficacy, over-the-counter availability, and broad acceptance secure its position within the dermatological therapeutics market. This analysis evaluates current market dynamics, competitive landscape, manufacturing considerations, regulatory environment, and future price projections for benzoyl peroxide.

Market Overview

Global Demand and Market Size

Benzoyl peroxide's global market surpassed $500 million in 2022, driven by rising dermatological conditions and increased consumer awareness about skin health. The Compound Annual Growth Rate (CAGR) from 2017 to 2022 is estimated at approximately 4%, with North America and Europe leading due to high skincare awareness and established OTC markets. Emerging markets, including Asia-Pacific, are experiencing accelerated growth owing to rising disposable incomes and urbanization.

Market Segments

Benzoyl peroxide's products vary by concentration—2.5%, 5%, and 10%—and formulation type, including gels, creams, and washes. The over-the-counter segment dominates, with a growing niche for prescription formulations aimed at severe cases. The consumer-driven OTC segment accounts for over 70% of sales, highlighting widespread accessibility.

Competitive Landscape

Key Players

Major manufacturers include Johnson & Johnson, Galderma, and Glenmark Pharmaceuticals, alongside numerous regional producers. Patent protections are largely expired or not applicable, leading to a highly commoditized market characterized by generic availability.

Manufacturing and Supply Chain

Benzoyl peroxide's production requires stability considerations, as it decomposes at high temperatures and in the presence of light. The synthesis involves the acetyl bleaching process, with raw materials like benzoyl chloride readily available. Production is relatively cost-efficient, with bulk synthesis driving down manufacturing costs, facilitating price competition.

Regulatory Environment

Benzoyl peroxide is classified as an over-the-counter dermatological ingredient in many markets, notably in the U.S., Canada, and the European Union. Regulatory agencies like the FDA and EMA approve its use at specified concentrations, simplifying market access. Nonetheless, regional regulations influence labeling, packaging, and permissible concentrations, impacting distribution.

Pricing Dynamics

Current Pricing Landscape

The average retail price for OTC benzoyl peroxide products ranges from $5 to $15 per ounce, varying by strength, formulation, and brand. Generics comprise most of the market, exerting downward pressure on prices. Bulk purchasing by pharmacies and chain stores further reduces unit costs.

Factors Influencing Price Fluctuations

  • Raw Material Costs: Benzoyl chloride, the primary raw material, experienced price volatility in recent years due to supply chain disruptions, impacting the end-product price.
  • Manufacturing Costs: Automation and process optimization enhance margin stability, but regulatory compliance adds overhead.
  • Market Competition: High competition leads to price wars, particularly in saturated OTC segments.
  • Regulation and Approval: Changes in permissible concentrations or labeling requirements can affect production and distribution costs.

Future Price Projections (2023–2028)

Market Trends Impacting Pricing

  • Increased Competition: The influx of manufacturers in emerging markets is likely to maintain or reduce prices.
  • Technological Advances: Development of improved formulations with enhanced stability or reduced irritation potential might command premium pricing.
  • Consumer Preferences: Growing demand for natural and organic skincare products could shift some manufacturers toward premium positioning, slightly elevating prices.
  • Regulatory Changes: Stricter quality control and environmental regulations could marginally increase manufacturing costs, tempering price declines.

Projected Price Trajectory

For the next five years, wholesale prices are expected to decrease modestly at a CAGR of approximately 1.5%–2%, driven primarily by increased competition and manufacturing efficiencies. Retail prices will likely follow suit, with premium formulations and novel delivery mechanisms commanding higher price points, balancing the overall trend toward affordability.

Key Market Opportunities and Challenges

Opportunities

  • Expansion into developing markets due to increasing skin health awareness
  • Innovation in formulations to improve tolerability and efficacy
  • Integration into combination products for enhanced dermatological treatment

Challenges

  • Regulatory hurdles in new markets
  • Price sensitivity among consumers, especially in price-competitive regions
  • Raw material supply limitations, affecting cost stability

Conclusion

Benzoyl peroxide remains a vital dermatological agent with a stable global market and consistent demand. Price stability is anticipated over the next five years, primarily due to intense competition and manufacturing efficiencies. Opportunities for premium product development exist, although market entry barriers and raw material concerns require strategic navigation.


Key Takeaways

  • The global benzoyl peroxide market was valued above $500 million in 2022, with steady growth expected.
  • Over-the-counter products dominate, driven by affordability, accessibility, and consumer preference.
  • Competition and raw material costs predominantly influence pricing, with modest unit price declines projected.
  • Innovation and emerging market expansion offer growth prospects for manufacturers.
  • Regulatory environments remain favorable but necessitate ongoing compliance vigilance.

FAQs

1. What factors influence the price of benzoyl peroxide globally?
Pricing is primarily affected by raw material costs (benzoyl chloride), manufacturing efficiency, competition among generic producers, regulatory compliance costs, and regional market dynamics.

2. Will the price of benzoyl peroxide decrease significantly in the next five years?
Overall, prices are expected to decline gradually (CAGR 1.5%-2%), influenced by increasing competition and production efficiencies, although premium formulations may carry higher prices.

3. Are there regulatory challenges affecting benzoyl peroxide pricing?
While generally approved as an OTC ingredient, variations in permissible concentrations and labeling requirements across regions may impact manufacturing and distribution costs, subtly affecting prices.

4. How do emerging markets impact benzoyl peroxide pricing?
Growing demand and increased manufacturing presence in emerging markets can lead to lower prices globally due to heightened competition and local production advantages.

5. What opportunities exist for premium benzoyl peroxide formulations?
Innovations targeting improved stability, decreased irritation, or natural ingredients may command higher retail prices, opening avenues for differentiation and margin growth.


Sources:

  1. Market research reports (e.g., Grand View Research, 2023)
  2. Regulatory agencies (FDA, EMA) official publications
  3. Industry analyses and dermatology market data

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.